您当前所在的位置:首页 > 产品中心 > 产品信息
Sulfacytine_分子结构_CAS_17784-12-2)
点击图片或这里关闭

Sulfacytine

产品号 DB01298 公司名称 DrugBank
CAS号 17784-12-2 公司网站 http://www.ualberta.ca/
分子式 C12H14N4O3S 电 话 (780) 492-3111
分子量 294.32956 传 真
纯 度 电子邮件 david.wishart@ualberta.ca
保 存 Chembase数据库ID: 1150

产品价格信息

请登录

产品别名

标题
Sulfacytine
IUPAC标准名
4-amino-N-(1-ethyl-2-oxo-1,2-dihydropyrimidin-4-yl)benzene-1-sulfonamide
IUPAC传统名
sulfacytine
商标名
Renoquid
别名
Sulfacitinum [inn-latin]
1-ethyl N4-sulfanilylcytosin
Sulfacitina [inn-spanish]
N-sulfanilyl-l-ethylcytosine
1-ethyl-N-sulfanilylcytosine

产品登记号

PubChem CID 5322
PubChem SID 46505483
CAS号 17784-12-2

产品性质

溶解度 1.75 mg/mL at 37 oC [MERCK INDEX (1996); pH 5]

产品详细信息

详细说明 (English)
Item Information
Drug Groups approved
Description Sulfacytine is a short-acting sulfonamide. The sulfonamides are synthetic bacteriostatic antibiotics with a wide spectrum against most gram-positive and many gram-negative organisms. However, many strains of an individual species may be resistant. Sulfonamides inhibit multiplication of bacteria by acting as competitive inhibitors of p-aminobenzoic acid in the folic acid metabolism cycle. Bacterial sensitivity is the same for the various sulfonamides, and resistance to one sulfonamide indicates resistance to all. Most sulfonamides are readily absorbed orally. However, parenteral administration is difficult, since the soluble sulfonamide salts are highly alkaline and irritating to the tissues. The sulfonamides are widely distributed throughout all tissues. High levels are achieved in pleural, peritoneal, synovial, and ocular fluids. Although these drugs are no longer used to treat meningitis, CSF levels are high in meningeal infections.

Sulfacytine is a competitive inhibitor of the enzyme dihydropteroate synthetase. It inhibits bacterial synthesis of of dihydrofolic acid by preventing the condensation of the pteridine with para-aminobenzoic acid (PABA), a substrate of the enzyme dihydropteroate synthetase. The inhibited reaction is necessary in these organisms for the synthesis of folic acid.
Indication Used orally in the treatment of acute urinary tract infections.
Pharmacology Sulfacytine is a short-acting sulfonamide. The sulfonamides are synthetic bacteriostatic antibiotics with a wide spectrum against most gram-positive and many gram-negative organisms. However, many strains of an individual species may be resistant. Sulfonamides inhibit multiplication of bacteria by acting as competitive inhibitors of p-aminobenzoic acid in the folic acid metabolism cycle. Bacterial sensitivity is the same for the various sulfonamides, and resistance to one sulfonamide indicates resistance to all. Most sulfonamides are readily absorbed orally. However, parenteral administration is difficult, since the soluble sulfonamide salts are highly alkaline and irritating to the tissues. The sulfonamides are widely distributed throughout all tissues. High levels are achieved in pleural, peritoneal, synovial, and ocular fluids. Although these drugs are no longer used to treat meningitis, CSF levels are high in meningeal infections. Their antibacterial action is inhibited by pus.
Affected Organisms
Bacteria
Absorption Well absorbed following oral administration.

参考文献